Using a dye to help see cancer during vulvectomy for Paget's disease
Part of Cancer clinical trials.
This trial tests whether a fluorescent dye called fluorescein sodium can help surgeons see the edges of extramammary Paget's disease more clearly during vulvectomy, so they can remove all the cancer while sparing as much healthy tissue as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a type of Paget's disease (EMPD) that has not spread deep into the skin or beyond
- Your EMPD appears as a single, connected spot that the surgeon can see
- Your doctor plans to remove the cancer with surgery that does not require removing the clitoris, urethra, or anus, and expects to close the wound directly or with a simple skin flap
- You have not had an allergic reaction to fluorescein sodium in the past
- You have not had radiation therapy to the vulva or anus area
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is for women with a specific rare skin cancer called extramammary Paget’s disease (EMPD) in the vulvar or perianal area. The goal is to better understand the condition and test an approach for people with primary or returning (recurrent) disease in those locations.
This trial tests a dye (CYTALUX) that helps surgeons see endometrial cancer during surgery. You may be eligible if you have endometrial cancer and are scheduled for surgery.
This trial tests a dye that makes lung cancer cells glow during surgery, helping surgeons remove more of the tumor. It's for people who are already scheduled for lung cancer surgery.
This trial tests a new imaging technique that uses a special dye and light to help surgeons see exactly where the tumor ends during breast cancer surgery, so they can remove the whole tumor while sparing healthy tissue. It may help reduce the chance of leaving cancer cells behind.
This study tests a special light treatment (photodynamic therapy) for non-invasive Paget’s disease on the vulva that has come back after surgery. It may help by treating remaining abnormal skin cells where surgery may not remove everything.
This trial tests whether using a special fluorescent dye during laparoscopic surgery helps surgeons better see and remove rectal or sigmoid colon cancer. The goal is to see if this technique makes the surgery more precise and possibly improves outcomes.
Hear when a new Extramammary Paget's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.